Overview
Investors searching APEPE vs CRCLON usually want a clear market-cap and momentum snapshot. APEPE prints $1,880.40 (-0.20%) while CRCLON is at $1,880.40 (+0.90%), with volume edge currently on APEPE.
Quick winners
Full comparison
| Metric | APEPE | CRCLON |
|---|---|---|
| Price | $1,880.40 | $1,880.40 |
| Market Cap | $199.82M | $88.84M |
| FDV | — | — |
| Volume 24h | $5.03M | $344,374.00 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 161.00 | 275.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.50% | +3.50% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | APEPE | CRCLON |
|---|---|---|
| 1H | — | — |
| 24H | -0.20% | +0.90% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | APEPE | CRCLON |
|---|---|---|
| RSI | 54.31 | 54.31 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 66.45 | 66.45 |
| ADX | 20.44 | 20.44 |
| Support | 1,827.82 | 1,827.82 |
| Resistance | 1,960.30 | 1,960.30 |
| Trend | bearish | bearish |
| Momentum | 59.00 | 59.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Technically, APEPE shows RSI 54.31 with trend bias bearish, while CRCLON sits at RSI 54.31 (bearish). Divergences between momentum and price should be confirmed on higher timeframes.
Fundamentals
| Metric | APEPE | CRCLON |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | — |
| Github activity | — | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
APEPE
CRCLON
Pros and cons
Pros of APEPE
- APEPE often anchors narratives that attract sustained media and analyst coverage.
- Market-cap scale on APEPE may dampen some idiosyncratic shocks versus smaller peers.
- Composite PEPS readings for APEPE can surface clearer module agreement during trend phases.
- APEPE typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
Cons of APEPE
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Indicator stacks on APEPE may stay stretched longer than expected in strong trends.
- Large-cap status for APEPE can mean slower percentage upside versus high-beta alternatives.
Pros of CRCLON
- If technical momentum aligns, CRCLON may outperform on medium-term windows.
- PEPS tracking for CRCLON still includes AI score and level context for monitoring.
- Diversifying versus APEPE with CRCLON can change portfolio factor exposure.
- CRCLON can offer higher relative beta when market attention rotates toward its niche.
Cons of CRCLON
- Relative underperformance versus APEPE can persist through entire market regimes.
- Higher volatility on CRCLON cuts both ways and demands stricter risk limits.
- Trend failures on CRCLON often travel faster than on more established assets.
Which looks stronger right now?
On the latest snapshot, market-cap leadership belongs to APEPE, while short-term performance leans toward CRCLON. That mix suggests relative strength can flip quickly, so size risk accordingly.
AI summary
Comparing APEPE and CRCLON begins with structure: capitalization, volume and rank. Present prints are $1,880.40 versus $1,880.40. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate CRCLON-vs-APEPE pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, APEPE or CRCLON?
“Better” depends on horizon and risk. APEPE leads on market cap today, while CRCLON leads the 24h move — neither is a guarantee.
Which has more upside potential, APEPE or CRCLON?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both APEPE and CRCLON.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. APEPE currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is CRCLON, but longer windows can disagree.